Imed Infinity Medical-Limited Partnership

Tel Aviv Stock Exchange IMED.TA

Imed Infinity Medical-Limited Partnership Net Income Margin for the year ending December 31, 2023

Imed Infinity Medical-Limited Partnership Net Income Margin is NA for the year ending December 31, 2023. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • Imed Infinity Medical-Limited Partnership Net Income Margin for the year ending December 31, 2022 was -503.00%, a 50.75% change year over year.
  • Imed Infinity Medical-Limited Partnership Net Income Margin for the year ending December 31, 2021 was -1,021.33%.
Key data
Date Net Income Margin EBITDA Margin EBIT Margin EBITDA
Market news
Tel Aviv Stock Exchange: IMED.TA

Imed Infinity Medical-Limited Partnership

CEO Mr. Itay Gal-Or
IPO Date Jan. 4, 2021
Location Israel
Headquarters Azrieli Tower
Employees 55
Sector Industrials
Industries
Research & Consulting Telehealth
Description

Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. The company was incorporated in 2020 and is based in Tel Aviv, Israel.

StockViz Staff

January 15, 2025

Any question? Send us an email